Trump and pharma execs to discuss progress on COVID-19 cure
The White House task force and the US President will meet drug makers this afternoon to discuss "progress on a vaccine and cure".
In an early morning Tweet, US President Trump said he will be meeting with major pharmaceutical companies today at the White House to discuss "progress on a vaccine and cure" for coronavirus (COVID-19) outbreak. This statement comes after the infection claimed the country's second victim during the weekend.
Although Trump provided no further information or details, including clues as to which companies would be attending, it has been reported that executives from Sanofi, Johnson & Johnson, GSK and Pfizer will be appearing at this afternoon's meeting.
The head of the infectious diseases unit at the US National Institutes of Health, Dr Anthony Fauci, said he was concerned the number of US cases could jump in the coming weeks.
“When you have a number of cases that you’ve identified and they’ve been in the community for a while, you’re going to wind up seeing a lot more cases than you would have predicted,” he told CNN in an interview on Monday. He continued to explain his concern that "we’re going to see a lot more community-related cases" during the next few weeks.
Meanwhile, on the other side of the Atlantic, Prime Minister Boris Johnson, has said the spread of coronavirus is a "problem that is likely to become more significant".
Johnson's comment comes as the number of cases in the UK rises to 40. The prime minister has also chaired a meeting today of the government's emergency committee, Cobra, to agree a plan to tackle the crisis.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance